Von Willebrand Factor and Pulmonary Vascular Endothelial Cell Dysfunction. Prognostic Implications;Fator von Willebrand e Disfunção Endotelial Pulmonar. Implicações Prognósticas

Arquivos Brasileiros de Cardiologia

Volumn 70, Issue 3, 1998, Pages 141-145

  Lopes, Antonio Augusto B ^a,b   Maeda, Nair Yukie ^a   Bydlowski, Sérgio Paulo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Endothelial cell; Pulmonary hypertension; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; PULMONARY HYPERTENSION; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MIDDLE AGED; PROGNOSIS; VON WILLEBRAND FACTOR;

EID: 0032015010     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ruggeri ZM, Ware J-von Willebrand factor FASEBJ 1993;7:308-16.
2. Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ - Structure-functionrelationship of human von Willebrand factor Blood 1987; 70: 605-11.
3. Sadler JE - von Willebrand factor. J Biol Chem 1991;266:22777-80.
4. Tsai HM, Nagel RL, Hatcher VB, Sussman II - Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases. Biochem Biophys Res Commun 1989; 158. 980-5.
5. Ribes JA, Francis CW, Wagner DD - Fibrin induces release of von Willebrand factor from endothelial cells J Clin Invest 1987; 79: 117-23.
6. Schores AE, Moldow CF, Rick ME - Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells Br J Haematol 1987; 67: 193-7
7. Zavoico GB, Ewenstein BM, Schafer AI, Pober JS - IL-I and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothehal cells without affecting thrombin stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis J Immunol 1989; 142. 3993-9.
8. Paleolog EM, Crossman DC, McVey JH, Pearson JD - Differential regulationby cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 1990; 75: 688-95
9. Tannenbaum SH, Gralnick HR - Gama-interferon modulates von Willebrand factor release by cultured human endothelial cells. Blood 1990, 75: 2177-84
10. Vander Poll T, Van Deventer SJH, Pasterkamp G, Van Mourick JA, Búller HR, Ten Cate JW - Tumor necrosis factor induces von Willebrand factor release in healthy humans Thromb Haemost 1992; 67: 623-6.
11. Kahaleh MB, Osborn I, LeRoy EC - Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon Ann Intern Med 1981, 94. 482-4.
12. Carvalho ACA, Bellman SM, Saullo VJ et al - Altered factor VIII in acute respiratory failure. N Engl J Med 1982, 307. 1113-19.
13. Kelton JG, Moore J, Santos A, Shendan D - The detection of a platelet-agglutination factor in thrombotic thrombocytopenic purpura Ann Intern Med 1984; 101: 589-93
14. Brenner B, Zwang E, Bronshtein M, Seligsohn U - von Willebrand factor multuner patterns in pregnancy-induced hypertension Thromb Haemost 1989; 62 715-17
15. Rubin DB, Wiener-Kronish JP, Murray JF et al - Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome J Clin Invest 1990, 86 474-80.
16. Blann AD, Midley HS, Burrows G et al - Oxygen free radicals, reperfusion injury, endothelial cells, and von Willebrand factor Cardiovasc Res 1993, 27 141-2
17. American College of Chest Physicians Consensus Statement - Primary pulmonary hypertension. Chest 1993; 104: 236-50.
18. McGoon MD - Prognosis and natural history In: Rubin LJ, Rich S, eds - Primary Pulmonary Hypertension New York: Marcel Dekker, 1997: 305-18.
19. Rabinovitch M, Andrew M, Thom H et al - Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. Circulation 1987, 76 1043-52
20. Lopes AAB, MaedaNY, Aiello VD et al - Abnormal multimeric and oligomeric composition is associated with enhanced enduthelal expression of von Willebrand factor in pulmonary hypertension Chest 1993, 104. 1455-60.
21. Fernandez Ginsberg MH, Ruggeri ZM, Batle FJ, ZimmermanTS - Multimeric structure of platelet factor VIII/von Willebrand: The presence of larger multimers and their association with thrombin-stimulated platelets Blood 1982, 60: 1132-8.
22. Lopes AAB, Maeda NY, Almeida A, Jaeger R, Ebaid M, Chamone DF - Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology 1993, 44 701-6
23. Berkowitz SD, Federici AB - Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal protelytic cleavage. Blood 1988, 72: 1790-6.
24. Cacoub P, Karmochkine M, Dorent R et al - Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996; 101: 160-4
25. Yoshibayashi M, Nishioka K, Nakao K et al - Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991; 84: 2280-5
26. Giaid A, Yanagisawa M, Langleben D et al - Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993, 328: 1732-9
27. Christman BW, Mc Pherson CD, Newman JH et al - An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 1992; 327: 70-5.
28. Uren NG, Ludman PF, Crake T et al - Response of the pulmonary circulation acetylcholine, calcitonin gene-related peptide, substance P and oral incardipine in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992, 19 835-41